down arrow

Prenetics Global Ltd.

  • Market Cap: Micro Cap
  • Industry: Finance
  • ISIN: KYG722451229
USD
13.93
-0.21 (-1.49%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

12.9314.31

52 Week

3.0917.87
Valuation
Technical
Day's Volume

CASH

138.09 k

Shareholding (Dec 2024)

FII

7.51%

Held by 9 FIIs

DII

77.4%

Held by 0 DIIs

Promoter

15.03%

What does Prenetics Global Ltd. do?

22-Jun-2025

Prenetics Global Ltd. is a micro-cap company in the finance industry, reporting net sales of $10 million and a net loss of $18 million as of December 2024, with a market cap of $98.94 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -24.37%.

Overview:<BR>Prenetics Global Ltd. operates in the finance industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 10 Million (Quarterly Results - Dec 2024)<BR>Most recent Net Profit: -18 Million (Quarterly Results - Dec 2024)<BR>Market-cap: USD 98.94 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making)<BR>Industry P/E: NA<BR>Dividend Yield: 0.00%<BR>Debt Equity: -0.37<BR>Return on Equity: -24.37%<BR>Price to Book: 0.61<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Prenetics Global Ltd. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, Prenetics Global Ltd. is considered overvalued due to its high price-to-earnings ratio of 45.2 compared to the industry average of 25.7, a price-to-sales ratio of 8.3 versus 4.5, and a return on equity of 5.1% that falls short of the peer average of 10.2%.

As of 5 October 2023, Prenetics Global Ltd. has moved from fair to overvalued. The company's current price-to-earnings ratio stands at 45.2, significantly higher than the industry average of 25.7, indicating that investors are paying a premium for its earnings. Additionally, the price-to-sales ratio is at 8.3, while the industry average is 4.5, further suggesting overvaluation. The return on equity is reported at 5.1%, which is lower than the peer average of 10.2%, highlighting potential inefficiencies in generating profit from equity.<BR><BR>In comparison to peers such as LabCorp with a price-to-earnings ratio of 18.5 and Quest Diagnostics at 20.3, Prenetics appears to be priced excessively high relative to its earnings potential. This overvaluation is compounded by the company's recent stock performance, which has lagged behind the Sensex, reinforcing the notion that the current market price may not be justified given its financial metrics.

Read More

Is Prenetics Global Ltd. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Prenetics Global Ltd. to determine a bullish or bearish outlook.

As of 1 October 2023, the technical data for Prenetics Global Ltd. is insufficient to form a view on whether it is bullish or bearish.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Positive results in Jun 25

  • NET PROFIT(HY) Higher at USD -20.19 MM
  • DEBTORS TURNOVER RATIO(HY) Highest at 17.53 times
  • NET SALES(Q) Highest at USD 17.68 MM
2

Risky - Negative EBITDA

3

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Finance

stock-summary
Market cap

USD 124 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.37

stock-summary
Return on Equity

-24.37%

stock-summary
Price to Book

0.77

Revenue and Profits:
Net Sales:
17 Million
(Quarterly Results - Mar 2025)
Net Profit:
-11 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
71.98%
0%
71.98%
6 Months
84.99%
0%
84.99%
1 Year
223.95%
0%
223.95%
2 Years
220.23%
0%
220.23%
3 Years
669.66%
0%
669.66%
4 Years
-90.62%
0%
-90.62%
5 Years
0%
0%
0.0%

Prenetics Global Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Prenetics Global Hits New 52-Week High of $6.38, Up 106.54%

Prenetics Global Hits New 52-Week High of $6.38, Up 106.54%

Prenetics Global has achieved a 52-week high of $6.38, reflecting a significant increase from its low of $3.09 and a one-year performance of 106.54%. The company, with a market cap of $124 million, remains unprofitable and has a negative return on equity, indicating ongoing financial challenges.

Read More
Prenetics Global Hits New 52-Week High of $7.10, Up 129.87%

Prenetics Global Hits New 52-Week High of $7.10, Up 129.87%

Prenetics Global has achieved a 52-week high of $7.10, reflecting a significant one-year performance increase. With a market capitalization of $124 million, the company is classified as a microcap and currently operates at a loss, indicated by its negative return on equity and absence of a price-to-earnings ratio.

Read More
Prenetics Global Hits New 52-Week High of $6.42, Up 107.89%

Prenetics Global Hits New 52-Week High of $6.42, Up 107.89%

Prenetics Global has achieved a 52-week high of $6.40, reflecting significant growth with a 107.89% increase in stock price over the past year. Despite being unprofitable, the company has a market capitalization of $124 million and notable financial metrics, highlighting its position in the microcap finance sector.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
249.03%
EBIT Growth (5y)
-294.32%
EBIT to Interest (avg)
-35.39
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
1.13
Tax Ratio
13.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
22.92%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.64
EV to EBIT
-0.97
EV to EBITDA
-1.17
EV to Capital Employed
0.45
EV to Sales
1.62
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-46.12%
ROE (Latest)
-22.01%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 1 Schemes (0.06%)

Foreign Institutions

Held by 9 Foreign Institutions (7.51%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 64.76% vs 34.62% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 37.14% vs -45.83% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.30",
          "val2": "10.50",
          "chgp": "64.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.80",
          "val2": "-17.90",
          "chgp": "45.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-8.70",
          "chgp": "98.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.00",
          "val2": "-17.50",
          "chgp": "37.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-632.20%",
          "val2": "-1,703.00%",
          "chgp": "107.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 41.01% vs -92.13% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.70% vs 70.39% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.60",
          "val2": "21.70",
          "chgp": "41.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-45.00",
          "val2": "-44.70",
          "chgp": "-0.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.10",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.80",
          "val2": "-7.70",
          "chgp": "-14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-49.80",
          "val2": "-56.40",
          "chgp": "11.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,661.90%",
          "val2": "-2,415.20%",
          "chgp": "75.33%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
17.30
10.50
64.76%
Operating Profit (PBDIT) excl Other Income
-9.80
-17.90
45.25%
Interest
0.10
0.10
Exceptional Items
-0.10
-8.70
98.85%
Consolidate Net Profit
-11.00
-17.50
37.14%
Operating Profit Margin (Excl OI)
-632.20%
-1,703.00%
107.08%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2025 is 64.76% vs 34.62% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 37.14% vs -45.83% in Dec 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
30.60
21.70
41.01%
Operating Profit (PBDIT) excl Other Income
-45.00
-44.70
-0.67%
Interest
0.20
0.10
100.00%
Exceptional Items
-8.80
-7.70
-14.29%
Consolidate Net Profit
-49.80
-56.40
11.70%
Operating Profit Margin (Excl OI)
-1,661.90%
-2,415.20%
75.33%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 41.01% vs -92.13% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 11.70% vs 70.39% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Prenetics Global Ltd. stock-summary
stock-summary
Prenetics Global Ltd.
Finance
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."